A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson Disease
NCT06650319
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Wilson Disease
Interventions
GENETIC:
LY-M003
Sponsor
Chaohui Yu